UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

The HIT Expert Probability (HEP) Score: a novel pre‐test probability model for heparin‐induced thrombocytopenia based on broad expert opinion

Journal of thrombosis and haemostasis, 2010-12, Vol.8 (12), p.2642-2650

2010

Volltextzugriff (PDF)

RIBBON-2: A Randomized, Double-Blind, Placebo-Controlled, Phase III Trial Evaluating the Efficacy and Safety of Bevacizumab in Combination With Chemotherapy for Second-Line Treatment of Human Epidermal Growth Factor Receptor 2–Negative Metastatic Breast Cancer

Breast diseases, 2012-01, Vol.23 (4), p.375-376

2012

Volltextzugriff (PDF)

Abstract P5-18-20: Phase II study of pertuzumab, trastuzumab, and weekly paclitaxel in patients with metastatic HER2-overexpressing metastatic breast cancer

Cancer research (Chicago, Ill.), 2012-12, Vol.72 (24_Supplement), p.P5-P5-18-20

2012

Volltextzugriff (PDF)

Treatment of Type 2 Diabetes in Childhood Using a Very-Low-Calorie Diet

Diabetes care, 2004-02, Vol.27 (2), p.348-353

2004

Volltextzugriff (PDF)

Abstract P2-08-01: PIK3CA mutations associate with decreased Ki67 in early stage breast cancer (BC) and better outcomes in patients even among those with low Ki67 tumors

Cancer research (Chicago, Ill.), 2012-12, Vol.72 (24_Supplement), p.P2-P2-08-01

2012

Volltextzugriff (PDF)

Abstract P6-05-01: Evaluation of the prognostic significance of androgen receptor (AR) expression in relation to ER expression in breast cancer (BC)

Cancer research (Chicago, Ill.), 2012-12, Vol.72 (24_Supplement), p.P6-P6-05-01

2012

Volltextzugriff (PDF)

Abstract P2-16-07: Phase II study of pertuzumab, trastuzumab, and weekly paclitaxel in patients with metastatic HER2-overexpressing metastatic breast cancer with cardiac biomarker data

Cancer research (Chicago, Ill.), 2013-12, Vol.73 (24_Supplement), p.P2-P2-16-07

2013

Volltextzugriff (PDF)

Convexity and Optimization in Banach Spaces

SIAM Review, 1980, Vol.22 (3), p.375-376

Datko, Richard F.

1980

Volltextzugriff (PDF)

Theory of Functional Differential Equations

SIAM Review, 1978-07, Vol.20 (3), p.610-612

Datko, Richard F.

1978

Volltextzugriff (PDF)

An Introduction to Optimal Control

SIAM Review, 1967-10, Vol.9 (4), p.764-765

Datko, R. F.

1967

Volltextzugriff (PDF)

Mathematical Methods of Optimal Control

SIAM Review, 1973, Vol.15 (1), p.231-232

Datko, Richard F.

1973

Volltextzugriff (PDF)

The Existence of Optimal Controls for a Performance Index with a Positive Integrand

SIAM journal on control, 1966-05, Vol.4 (2), p.372-381

1966

Volltextzugriff (PDF)

A Prolyl-Isomerase Mediates Dopamine-Dependent Plasticity and Cocaine Motor Sensitization

Cell, 2013-08, Vol.154 (3), p.637-650

2013

Volltextzugriff (PDF)

Interim safety analysis of phase IB trial of HER2 inhibitor tucatinib combined with PI3Kα inhibitor alpelisib in HER2+ PIK3CA -mutated metastatic breast cancer

Journal of clinical oncology, 2024-06, Vol.42 (16_suppl)

2024

Volltextzugriff (PDF)

Behavioral and Neurochemical Phenotyping of Mice Incapable of Homer1a Induction

Frontiers in behavioral neuroscience, 2017-11, Vol.11, p.208-208

2017

Volltextzugriff (PDF)

PIK3CA Mutations Drive Therapeutic Resistance in Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer

JCO precision oncology, 2022-03, Vol.6 (6), p.e2100370

2022

Volltextzugriff (PDF)

Distance Metrics in Open-Set Classification of Text Documents by Local Outlier Factor and Doc2Vec

Advances and Trends in Artificial Intelligence. From Theory to Practice, p.102-109

Volltextzugriff (PDF)

Abstract OT3-09-01: Clinical Trial of Alpelisib and Tucatinib in Patients with PIK3CA-Mutant HER2-Positive Metastatic Breast Cancer

Cancer research (Chicago, Ill.), 2023-03, Vol.83 (5_Supplement), p.OT3-09-01-OT3-09-01

2023

Volltextzugriff (PDF)

Abstract PD5-3: Phase I trial: PI3Kα inhibitor BYL719 plus aromatase inhibitor (AI) for patients with hormone receptor-positive (HR+) metastatic breast cancer (MBC)

Cancer research (Chicago, Ill.), 2015-05, Vol.75 (9_Supplement), p.PD5-3-PD5-3

2015

Volltextzugriff (PDF)

Phase I trial of daily PI3Kα inhibitor BYL719 plus letrozole (L) or exemestane (E) for patients (pts) with hormone receptor-positive (HR+) metastatic breast cancer (MBC)

Journal of clinical oncology, 2014-05, Vol.32 (15_suppl), p.2605-2605

2014

Volltextzugriff (PDF)

Surface Pressure-Induced Isotropic−Nematic Transition in Polymer MonolayersEffect of Solvent Molecules

Langmuir, 2000-05, Vol.16 (9), p.4319-4324

2000

Volltextzugriff (PDF)

Surface Pressure-Induced Isotropic−Nematic Transition in Polymer MonolayersEffect of Solvent Molecules

Langmuir, 2000-05, Vol.16 (9), p.4319-4324

2000

Volltextzugriff (PDF)

Comparison of inflammatory changes in established type II collagen- and adjuvant-induced arthritis using outbred wistar rats

International journal of immunopharmacology, 1985, Vol.7 (6), p.811-826

1985

Volltextzugriff (PDF)

The correlation of results of breath analysers and laboratory blood examinations of blood-ethanol concentration (Czech and Slovak study)

Soudni lekarstvi, 2010-01, Vol.55 (1), p.8

2010

Volltextzugriff (PDF)

Effect of a 5-lipoxygenase (5-LO)/cyclooxygenase (CO) inhibitor, WY-47, 288, on cutaneous models of inflammation

Agents and Actions, 1989-03, Vol.26 (3-4), p.319-328

1989

Volltextzugriff (PDF)

1 – 25 von 30

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(27)
Mit Volltextzugriff
(25)

Publikationsform

Sprache

Englisch
(29)
Tschechisch
(1)

Erscheinungsjahr

n.n

Thema

Science & Technology
(12)
Life Sciences & Biomedicine
(10)
Animals
(8)
Male
(7)
Female
(5)
Humans
(4)
Pharmacology & Pharmacy
(4)
Rats
(4)
Biological And Medical Sciences
(3)
Chemistry
(3)
Chemistry, Multidisciplinary
(3)
Disease Models, Animal
(3)
Medical Sciences
(3)
Mice
(3)
Physical Sciences
(3)
Antibody Formation
(2)
Arthritis - Immunology
(2)
Arthritis, Experimental - Drug Therapy
(2)
Arthritis, Experimental - Immunology
(2)
Cocaine
(2)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

The HIT Expert Probability (HEP) Score: a novel pre‐test probability model for heparin‐induced thrombocytopenia based on broad expert opinion

RIBBON-2: A Randomized, Double-Blind, Placebo-Controlled, Phase III Trial Evaluating the Efficacy and Safety of Bevacizumab in Combination With Chemotherapy for Second-Line Treatment of Human Epidermal Growth Factor Receptor 2–Negative Metastatic Breast Cancer

Abstract P5-18-20: Phase II study of pertuzumab, trastuzumab, and weekly paclitaxel in patients with metastatic HER2-overexpressing metastatic breast cancer

Treatment of Type 2 Diabetes in Childhood Using a Very-Low-Calorie Diet

Abstract P2-08-01: PIK3CA mutations associate with decreased Ki67 in early stage breast cancer (BC) and better outcomes in patients even among those with low Ki67 tumors

Abstract P6-05-01: Evaluation of the prognostic significance of androgen receptor (AR) expression in relation to ER expression in breast cancer (BC)

Abstract P2-16-07: Phase II study of pertuzumab, trastuzumab, and weekly paclitaxel in patients with metastatic HER2-overexpressing metastatic breast cancer with cardiac biomarker data

Convexity and Optimization in Banach Spaces

Theory of Functional Differential Equations

An Introduction to Optimal Control

Mathematical Methods of Optimal Control

The Existence of Optimal Controls for a Performance Index with a Positive Integrand

A Prolyl-Isomerase Mediates Dopamine-Dependent Plasticity and Cocaine Motor Sensitization

Interim safety analysis of phase IB trial of HER2 inhibitor tucatinib combined with PI3Kα inhibitor alpelisib in HER2+ PIK3CA -mutated metastatic breast cancer

Behavioral and Neurochemical Phenotyping of Mice Incapable of Homer1a Induction

PIK3CA Mutations Drive Therapeutic Resistance in Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer

Distance Metrics in Open-Set Classification of Text Documents by Local Outlier Factor and Doc2Vec

Abstract OT3-09-01: Clinical Trial of Alpelisib and Tucatinib in Patients with PIK3CA-Mutant HER2-Positive Metastatic Breast Cancer

Abstract PD5-3: Phase I trial: PI3Kα inhibitor BYL719 plus aromatase inhibitor (AI) for patients with hormone receptor-positive (HR+) metastatic breast cancer (MBC)

Phase I trial of daily PI3Kα inhibitor BYL719 plus letrozole (L) or exemestane (E) for patients (pts) with hormone receptor-positive (HR+) metastatic breast cancer (MBC)

Surface Pressure-Induced Isotropic−Nematic Transition in Polymer MonolayersEffect of Solvent Molecules

Surface Pressure-Induced Isotropic−Nematic Transition in Polymer MonolayersEffect of Solvent Molecules

Comparison of inflammatory changes in established type II collagen- and adjuvant-induced arthritis using outbred wistar rats

The correlation of results of breath analysers and laboratory blood examinations of blood-ethanol concentration (Czech and Slovak study)

Effect of a 5-lipoxygenase (5-LO)/cyclooxygenase (CO) inhibitor, WY-47, 288, on cutaneous models of inflammation

Suchergebnisse filtern